The CMS ACCESS Model—Advancing Chronic Care with Effective, Scalable Solutions—allows Mindset Health to provide its therapy to patients who meet specific criteria within the program's behavioral health and musculoskeletal tracks. While the model is designed to reward evidence-based care, eligibility is tied to these broader clinical categories rather than a primary diagnosis of Irritable Bowel Syndrome (IBS). Nerva combines CBT-informed coaching, breathing exercises, and gut-directed hypnotherapy to manage disorders of the gut-brain interaction.

Co-founder and Co-CEO Alex Naoumidis noted that while clinical evidence for these therapies has long existed, financial barriers previously kept them out of reach for many seniors. Beyond the CMS model, the company is exploring alternative access routes for patients aged 65 and older. This rollout follows a 2025 study published in the American Journal of Gastroenterology, which reported that 81% of participants experienced significant symptom management improvements. Ongoing research collaborations with institutions like the Mayo Clinic and Mount Sinai continue to underpin the program's methodology.